GO
| HSI1 | 25,818.93 | +44.79 | 92.52B |
| HSCEI1 | 8,915.12 | +1.29 | 34.27B |
| Back Zoom + Zoom - Block Traded | |
|
Novo Nordisk Soars 10% Post-Mkt as Oral Weight Loss Drug Receives FDA Approval
2025-12-23 08:48:18 Novo Nordisk A/S (NVO.US) has received approval from the US Food and Drug Administration (FDA) for an oral weight loss drug, which will compete with rival Eli Lilly and Company (LLY.US) in the weight loss drug market. Following the approval announcement, Novo Nordisk's stock price rose by 10.56% to USD53.18 in after-hours trading. ~ AAStocks Financial News Web Site: www.aastocks.com | |